FFL Partners, a private equity firm, and Two Sigma Impact, the impact investing business of Two Sigma, have acquired a majority ownership of Community Medical Services, a high growth opioid treatment program provider.

CMS operates over 45 clinics across 9 states that provide high-efficacy opioid use disorder treatment. The deal will provide the firm with additional resources to help evolve the treatment of opioid addiction.

The investment by the two firms follows the growing opiod epidemic as OUD care is one of the largest and fastest growing segments of US healthcare currently suffering form supply chain constraint.

“One of the most disturbing aspects of the opioid crisis in this country is that the gap between the volume of people in need of treatment and the availability of high-quality treatment grows exponentially larger each year,” added Nick Stavros, CMS CEO. “CMS is committed to not just providing the highest quality treatment to those suffering from opioid-use disorders but also to changing the way society views addiction and addiction treatment.”

CMS was advised by Houlihan Lokey and Alston & Bird LLP, while FFL and Two Sigma Impact were advised by Willkie Farr & Gallagher LLP.